U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07193407) titled 'INOPASE - Performance and Safety Study of a Personalised SNM System' on Sept. 10.
Brief Summary: The goal of this clinical trial is to learn whether a new sacral neuromodulation (SNM) system (INO-SNM-01) can safely and effectively sense bladder nerve activity and provide stimulation to help manage symptoms of refractory overactive bladder in adult women aged 18-70 who have not responded to standard treatments.
The main questions it aims to answer are:
* Is there a clear relationship between bladder nerve activity and patient-reported urgency sensations?
* Can targeted stimulation based on bladder nerve activity reduce overactive...